Clinical Pathology

Last Fall I wrote a couple of posts about the growing disenchantment with 'Pinkification' and 'Pinktober' referencing the all-out blitz during October to go "Pink" for breast bancer awareness and prevention.  In one of the pieces I mentioned...

Science, health care and technology conglomerate Danaher Corp. DHR 0.28 % said Tuesday that it would buy molecular-diagnostics company Cepheid Inc. CPHD -0.20 % for $53.00 a share, in its first major acquisition since spinning off a...

Published August 29, 2016 By Simon Häger, Product Manager Sectra Digital Pathology Solution Although most pathology departments have not yet made the transition to digital, many are actively evaluating the business case. Why? Most...

High throughput whole slide imaging for Digital Pathology via an affordable monthly subscription without a capital expense SUNNYVALE, CA -- OptraSCAN announces it has launched its 120-slide Whole Slide Imaging scanner as part of its On-Demand...

I love headlines such as these. First it was "Pigeons to Replace Pathologists in Diagnosing Benign from Malignant Tumors" now it is actual computer algorithms that get it right more times than and more so than ordinary surgical pathologists!...

When serum protein biomarker data were used independently, clinical sensitivity and specificity for detection of breast cancer were 74.7% and 77.0%, respectively. When tumor-associated autoantibody data were used independently,...